BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 30289463)

  • 1. Engineered dCas9 with reduced toxicity in bacteria: implications for genetic circuit design.
    Zhang S; Voigt CA
    Nucleic Acids Res; 2018 Nov; 46(20):11115-11125. PubMed ID: 30289463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective Blocking of Microbial Transcriptional Initiation by dCas9-NG-Mediated CRISPR Interference.
    Kim B; Kim HJ; Lee SJ
    J Microbiol Biotechnol; 2020 Dec; 30(12):1919-1926. PubMed ID: 32958732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid generation of CRISPR/dCas9-regulated, orthogonally repressible hybrid T7-lac promoters for modular, tuneable control of metabolic pathway fluxes in Escherichia coli.
    Cress BF; Jones JA; Kim DC; Leitz QD; Englaender JA; Collins SM; Linhardt RJ; Koffas MA
    Nucleic Acids Res; 2016 May; 44(9):4472-85. PubMed ID: 27079979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. dCas9 regulator to neutralize competition in CRISPRi circuits.
    Huang HH; Bellato M; Qian Y; Cárdenas P; Pasotti L; Magni P; Del Vecchio D
    Nat Commun; 2021 Mar; 12(1):1692. PubMed ID: 33727557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-input CRISPR/Cas genetic circuits that interface host regulatory networks.
    Nielsen AA; Voigt CA
    Mol Syst Biol; 2014 Nov; 10(11):763. PubMed ID: 25422271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Competitive dCas9 binding as a mechanism for transcriptional control.
    Anderson DA; Voigt CA
    Mol Syst Biol; 2021 Nov; 17(11):e10512. PubMed ID: 34747560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulated Expression of sgRNAs Tunes CRISPRi in E. coli.
    Fontana J; Dong C; Ham JY; Zalatan JG; Carothers JM
    Biotechnol J; 2018 Sep; 13(9):e1800069. PubMed ID: 29635744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPRi-mediated tunable control of gene expression level with engineered single-guide RNA in Escherichia coli.
    Byun G; Yang J; Seo SW
    Nucleic Acids Res; 2023 May; 51(9):4650-4659. PubMed ID: 36999618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Programmable CRISPR-Cas transcriptional activation in bacteria.
    Ho HI; Fang JR; Cheung J; Wang HH
    Mol Syst Biol; 2020 Jul; 16(7):e9427. PubMed ID: 32657546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orthogonal tuning of gene expression noise using CRISPR-Cas.
    Wu F; Shim J; Gong T; Tan C
    Nucleic Acids Res; 2020 Jul; 48(13):e76. PubMed ID: 32479612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR/dCas9-Mediated Multiplex Gene Repression in Streptomyces.
    Zhao Y; Li L; Zheng G; Jiang W; Deng Z; Wang Z; Lu Y
    Biotechnol J; 2018 Sep; 13(9):e1800121. PubMed ID: 29862648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene silencing with CRISPRi in bacteria and optimization of dCas9 expression levels.
    Depardieu F; Bikard D
    Methods; 2020 Feb; 172():61-75. PubMed ID: 31377338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous repression of multiple bacterial genes using nonrepetitive extra-long sgRNA arrays.
    Reis AC; Halper SM; Vezeau GE; Cetnar DP; Hossain A; Clauer PR; Salis HM
    Nat Biotechnol; 2019 Nov; 37(11):1294-1301. PubMed ID: 31591552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward tunable dynamic repression using CRISPRi.
    Jang S; Jang S; Jung GY
    Biotechnol J; 2018 Sep; 13(9):e1800152. PubMed ID: 29714047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cas9 off-target binding to the promoter of bacterial genes leads to silencing and toxicity.
    Rostain W; Grebert T; Vyhovskyi D; Pizarro PT; Tshinsele-Van Bellingen G; Cui L; Bikard D
    Nucleic Acids Res; 2023 Apr; 51(7):3485-3496. PubMed ID: 36929199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPathBrick: Modular Combinatorial Assembly of Type II-A CRISPR Arrays for dCas9-Mediated Multiplex Transcriptional Repression in E. coli.
    Cress BF; Toparlak ÖD; Guleria S; Lebovich M; Stieglitz JT; Englaender JA; Jones JA; Linhardt RJ; Koffas MA
    ACS Synth Biol; 2015 Sep; 4(9):987-1000. PubMed ID: 25822415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orthogonal Modular Gene Repression in Escherichia coli Using Engineered CRISPR/Cas9.
    Didovyk A; Borek B; Hasty J; Tsimring L
    ACS Synth Biol; 2016 Jan; 5(1):81-8. PubMed ID: 26390083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanding the Scope of Bacterial CRISPR Activation with PAM-Flexible dCas9 Variants.
    Kiattisewee C; Karanjia AV; Legut M; Daniloski Z; Koplik SE; Nelson J; Kleinstiver BP; Sanjana NE; Carothers JM; Zalatan JG
    ACS Synth Biol; 2022 Dec; 11(12):4103-4112. PubMed ID: 36378874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR-Mediated Transcriptional Repression in Toxoplasma gondii.
    Markus BM; Boydston EA; Lourido S
    mSphere; 2021 Oct; 6(5):e0047421. PubMed ID: 34643425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enabling Graded and Large-Scale Multiplex of Desired Genes Using a Dual-Mode dCas9 Activator in Saccharomyces cerevisiae.
    Deaner M; Mejia J; Alper HS
    ACS Synth Biol; 2017 Oct; 6(10):1931-1943. PubMed ID: 28700213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.